[go: up one dir, main page]

TN2011000019A1 - PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF - Google Patents

PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF

Info

Publication number
TN2011000019A1
TN2011000019A1 TN2011000019A TN2011000019A TN2011000019A1 TN 2011000019 A1 TN2011000019 A1 TN 2011000019A1 TN 2011000019 A TN2011000019 A TN 2011000019A TN 2011000019 A TN2011000019 A TN 2011000019A TN 2011000019 A1 TN2011000019 A1 TN 2011000019A1
Authority
TN
Tunisia
Prior art keywords
pharmaceutical composition
micronized progesterone
composition based
relates
safflower oil
Prior art date
Application number
TN2011000019A
Other languages
French (fr)
Inventor
Jennifer Gicquel
Didier Terracol
Roland Samoyeau
Original Assignee
Effik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/FR2009/052461 external-priority patent/WO2011001039A1/en
Application filed by Effik filed Critical Effik
Publication of TN2011000019A1 publication Critical patent/TN2011000019A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition pharmaceutique contenant de la progestérone micronisée et au moins une huile de carthame oléique dite huile de carthame de type II. Elle concerne également des médicaments comprenant ladite composition pharmaceutique. L'invention concerne en outre les utilisations médicales de cette composition pharmaceutique.The present invention relates to a pharmaceutical composition containing micronized progesterone and at least one oleic safflower oil known as safflower oil type II. It also relates to medicaments comprising said pharmaceutical composition. The invention further relates to the medical uses of this pharmaceutical composition.

TN2011000019A 2009-12-09 2011-01-20 PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF TN2011000019A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR2009/052461 WO2011001039A1 (en) 2009-06-29 2009-12-09 Micronised progesterone pharmaceutical composition and uses thereof

Publications (1)

Publication Number Publication Date
TN2011000019A1 true TN2011000019A1 (en) 2012-09-05

Family

ID=55024335

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000019A TN2011000019A1 (en) 2009-12-09 2011-01-20 PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF

Country Status (1)

Country Link
TN (1) TN2011000019A1 (en)

Similar Documents

Publication Publication Date Title
MA32548B1 (en) Pharmaceutical composition of progesterone and its uses
MA33761B1 (en) Solid dispersion of reximine
MA37809B1 (en) Biodegradable drug delivery for hydrophobic compositions
MA39094B1 (en) Combination therapy comprising an mdm2 inhibitor and one or more additional pharmaceutically active ingredients for the treatment of cancers
MX2007001553A (en) Novel statin pharmaceutical compositions and related methods of treatment.
MA38567A1 (en) Variants of pertuzumab and their evaluation
MA32876B1 (en) ANTIBODIES AGAINST ANGIOPOIETIN 2 HUMAN
MA40814A1 (en) Pharmaceutical compositions for combination therapy
MA30358B1 (en) QUINAZOLINES FOR THE INHIBITION OF PDK1
MA30975B1 (en) PARENTERAL FORMULATION OF ABETA ANTI-PEPTIDE ANTIBODY
TW200626136A (en) Low oil emulsion compositions for delivering taxoids and other insoluble drugs
BR0210139A (en) Pharmaceutical Compositions
FR2999924B1 (en) ASSEMBLY COMPRISING AT LEAST ONE ESSENTIAL OIL, A CYCLODEXTRIN AND A LIQUID FATTY BODY AND COMPOSITION CONTAINING SAME.
UA103930C2 (en) Normal;heading 1;heading 2;heading 3;COMPOUNDS AND COMPOSITION FOR THE TREATMENT OF PARASITIC DISEASES
MA34670B1 (en) APOPTOSIS INHIBITORS AND USES THEREOF
MA32458B1 (en) COMBINATION OF A C-MET ANTAGONIST AND AN AMINOHETEROARYL COMPOUND FOR THE TREATMENT OF CANCER
NO20070580L (en) Treatment of cancer.
MA35874B1 (en) Cyclic amide derivatives for use as 11-beta-hydroxysteroid dehydrogenase inhibitors and uses thereof
CY1109537T1 (en) Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION
MA35875B1 (en) Derivatives of aza-adamantane and their uses
DOP2011000335A (en) ANTITUMORAL COMBINATION INCLUDING AVE8062 AND SORAFENIB
MA31611B1 (en) NOVEL TETRAHYDRONAPHTHALENES SUBSTITUTED IN THEIR PREPARATION METHODS AND THEIR USE AS MEDICAMENTS
TN2011000019A1 (en) PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF
FR3073142B1 (en) COSMETIC FORMULATION
FR3057778B1 (en) NEW ACTIVE ADIPOCYTE COMPOSITIONS